Sowell Financial Services LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$1.39 - $2.21 $3,177 - $5,052	-2,286 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$1.27 - $3.42 $43 - $116	-34 Reduced 1.47%	2,286 $4,000
Q4 2020 Jan 13, 2021	BUY	$0.94 - $1.89 $660 - $1,328	703 Added 43.48%	2,320 $3,000
Q3 2020 Nov 12, 2020	SELL	$1.5 - $9.38 $39 - $243	-26 Reduced 1.58%	1,617 $3,000
Q2 2020 Aug 13, 2020	BUY	$4.79 - $8.39 $3,367 - $5,898	703 Added 74.79%	1,643 $14,000
Q3 2019 Nov 14, 2019	BUY	$4.87 - $7.08 $4,577 - $6,655	940 New	940 $5,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.